New drugs for old: disinvestment and NICE.
Hughes
Dyfrig A
DA
Centre for Economics and Policy in Health, Institute for Medical and Social Care Research, Bangor University, Bangor LL57 1UT. d.a.hughes@bangor.ac.uk
Ferner
Robin E
RE
D003659:Decision Making, Organizational; D017277:Drug Approval / Q000191:economics*; D016527:Drug Costs; D016568:Drugs, Generic / Q000191:economics; D010330:Patents as Topic; D004364:Pharmaceutical Preparations / Q000191:economics / Q000600:supply & distribution*; D055553:Prescription Drugs / Q000191:economics / Q000600:supply & distribution*; D013222:State Medicine / Q000191:economics; D013673:Technology Assessment, Biomedical; D006113:United Kingdom
D016568:Drugs, Generic; D004364:Pharmaceutical Preparations; D055553:Prescription Drugs